Article
A Panel of Diverse <i>Pseudomonas aeruginosa</i> Clinical Isolates for Research and Development
2021-04-24
Abstract excerpt
Pseudomonas aeruginosa is a leading cause of community-acquired and hospital-acquired infections. Successful treatment is hampered by its remarkable ability to rapidly develop resistance to antimicrobial agents, mostly through mutation. In response, the World Health Organization listed carbapenem-resistant P. aeruginosa as a Priority 1 (Critical) pathogen for research and development of new treatments. A key reso...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9f8bde70-30e8-5329-8561-9c4748be5813
- DOI
- 10.1101/2021.04.23.441230
